Literature DB >> 19732236

A rare connection: fasciculoventricular pathway in PRKAG2 disease.

Malini Govindan1, David Ward, Elijah Behr.   

Abstract

Mutations in the PRKAG2 gene that regulates the gamma 2 subunit of the AMP-dependent protein kinase A have been associated with the development of AV accessory pathways, cardiac hypertrophy, and conduction system abnormalities. The accessory pathways described in PRKAG2 disease have mostly been AV bypass tracts, as mutations in the PRKAG2 gene disrupt the normal AV junction development. There have also been a few reports of nodoventricular tracts associated with PRKAG2 mutations, as these tracts also involve the AV junction. We describe a case of a fasciculoventricular pathway with PRKAG2 mutation suggesting a more widespread involvement of the PRKAG2 gene in the development of the cardiac conduction system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732236     DOI: 10.1111/j.1540-8167.2009.01578.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  4 in total

Review 1.  Clinical Spectrum of PRKAG2 Syndrome.

Authors:  Andrea Giuseppe Porto; Francesca Brun; Giovanni Maria Severini; Pasquale Losurdo; Enrico Fabris; Matthew R G Taylor; Luisa Mestroni; Gianfranco Sinagra
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-01

2.  Mammalian γ2 AMPK regulates intrinsic heart rate.

Authors:  Arash Yavari; Mohamed Bellahcene; Annalisa Bucchi; Syevda Sirenko; Katalin Pinter; Neil Herring; Julia J Jung; Kirill V Tarasov; Emily J Sharpe; Markus Wolfien; Gabor Czibik; Violetta Steeples; Sahar Ghaffari; Chinh Nguyen; Alexander Stockenhuber; Joshua R St Clair; Christian Rimmbach; Yosuke Okamoto; Dongmei Yang; Mingyi Wang; Bruce D Ziman; Jack M Moen; Daniel R Riordon; Christopher Ramirez; Manuel Paina; Joonho Lee; Jing Zhang; Ismayil Ahmet; Michael G Matt; Yelena S Tarasova; Dilair Baban; Natasha Sahgal; Helen Lockstone; Rathi Puliyadi; Joseph de Bono; Owen M Siggs; John Gomes; Hannah Muskett; Mahon L Maguire; Youlia Beglov; Matthew Kelly; Pedro P N Dos Santos; Nicola J Bright; Angela Woods; Katja Gehmlich; Henrik Isackson; Gillian Douglas; David J P Ferguson; Jürgen E Schneider; Andrew Tinker; Olaf Wolkenhauer; Keith M Channon; Richard J Cornall; Eduardo B Sternick; David J Paterson; Charles S Redwood; David Carling; Catherine Proenza; Robert David; Mirko Baruscotti; Dario DiFrancesco; Edward G Lakatta; Hugh Watkins; Houman Ashrafian
Journal:  Nat Commun       Date:  2017-11-02       Impact factor: 14.919

3.  A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitation.

Authors:  Kun-Qi Yang; Chao-Xia Lu; Ying Zhang; Yan-Kun Yang; Jia-Cheng Li; Tian Lan; Xu Meng; Peng Fan; Tao Tian; Lin-Ping Wang; Ya-Xin Liu; Xue Zhang; Xian-Liang Zhou
Journal:  Sci Rep       Date:  2017-05-25       Impact factor: 4.379

4.  Left ventricular non-compaction cardiomyopathy associated with the PRKAG2 mutation.

Authors:  Jing Zhang; Xiu Han; Qun Lu; Yunfei Feng; Aiqun Ma; Tingzhong Wang
Journal:  BMC Med Genomics       Date:  2022-10-11       Impact factor: 3.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.